Does ARB therapy slow the rate of progressive aortic-root dilation in patients with Marfan's syndrome?
ARB therapy may significantly slow progressive aortic-root dilation in patients with Marfan's syndrome, though randomized trials are needed to confirm these findings.
In a small cohort study, the use of ARB therapy in patients with Marfan's syndrome significantly slowed the rate of progressive aortic-root dilation. These findings require confirmation in a randomized trial.
Brooke et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: